Cargando…

The Efficacy and Mid-term Durability of Urethral Sphincter Injections of Platelet-Rich Plasma in Treatment of Female Stress Urinary Incontinence

Aims: This study investigated the therapeutic effect of repeated urethral sphincter injections of autologous platelet-rich plasma (PRP) in treatment of stress urinary incontinence (SUI) in women due to intrinsic sphincter deficiency (ISD) refractory to medical treatment or after the first anti-incon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Ching-Hsiang, Kuo, Hann-Chorng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861290/ https://www.ncbi.nlm.nih.gov/pubmed/35211026 http://dx.doi.org/10.3389/fphar.2022.847520

Ejemplares similares

Therapeutic Efficacy and Mid-Term Durability of Urethral Sphincter Platelet-Rich Plasma Injections to Treat Postprostatectomy Stress Urinary Incontinence
por: Lee, Ping-Jui, et al.
Publicado: (2022)

A novel management for postprostatectomy urinary incontinence: platelet-rich plasma urethral sphincter injection
por: Lee, Ping-Jui, et al.
Publicado: (2021)

Therapeutic Efficacy of Urethral Sphincter Injections of Platelet-Rich Plasma for the Treatment of Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency: A Proof-of-Concept Clinical Trial
por: Jiang, Yuang-Hong, et al.
Publicado: (2021)

Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions
por: Lee, Yu-Khun, et al.
Publicado: (2019)

Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction
por: Kuo, Hann-Chorng
Publicado: (2016)

Botulinum Toxin A Injection for Autonomic Dysreflexia—Detrusor Injection or Urethral Sphincter Injection?
por: Chow, Po-Ming, et al.
Publicado: (2023)

Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors
por: Ou, Yin-Chien, et al.
Publicado: (2021)

Effectiveness of Platelet-Rich Plasma Injections as Prophylaxis for Recurrent Urinary Tract Infection in Women
por: Lee, Yu-Khun, et al.
Publicado: (2023)

Patients’ perspectives on urethral bulk injection therapy and mid-urethral sling surgery for stress urinary incontinence
por: Casteleijn, Fenne M., et al.
Publicado: (2018)

OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction – A Randomized, Double-Blind, Placebo-Controlled Study
por: Jiang, Yuan-Hong, et al.
Publicado: (2016)

Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?
por: Chen, Sheng-Fu, et al.
Publicado: (2023)

Bladder Ultrastructure and Urinary Cytokine Abnormality in Patients with Recurrent Urinary Tract Infection and the Changes after Intravesical Platelet-Rich Plasma Injections
por: Jhang, Jia-Fong, et al.
Publicado: (2022)

Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women
por: Jiang, Yuan-Hong, et al.
Publicado: (2021)

Prediction of Postradical Prostatectomy Urinary Incontinence Through the Combination of the Urethral Pressure Profile With Electromyography of the Urethral Sphincter
por: Talavera, Jonathan Rodríguez, et al.
Publicado: (2022)

Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection
por: Kao, Yao-Lin, et al.
Publicado: (2022)

The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction
por: Kao, Yao-Lin, et al.
Publicado: (2019)

Urinary Oxidative Stress Biomarkers in the Diagnosis of Detrusor Overactivity in Female Patients with Stress Urinary Incontinence
por: Chen, Wei-Hsin, et al.
Publicado: (2023)

The Evolution of Surgical Treatment for Female Stress Urinary Incontinence: Era of Mid-Urethral Slings
por: Lee, Young-Suk, et al.
Publicado: (2010)

Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Mid-urethral slings in female incontinence: Current status
por: Krlin, Ryan M., et al.
Publicado: (2011)

Voiding Dysfunction Due to Urethral Sphincter Dysfunction Might Be an Early Neurological Presentation of Central Nervous System Disorders in Aged Patients
por: Ho, Guan-Ru, et al.
Publicado: (2023)

Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
por: Ke, Qian-Sheng, et al.
Publicado: (2019)

Predictors for De Novo Overactive Bladder after Readjustable Mid-Urethral Sling Procedure in Women with Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency
por: No, Joo Hyun, et al.
Publicado: (2018)

Urethral injection of dedifferentiated fat cells ameliorates sphincter damage and voiding dysfunction in a rat model of persistence stress urinary incontinence
por: Murata, Yasutaka, et al.
Publicado: (2022)

TAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I study
por: Yono, Makoto, et al.
Publicado: (2020)

When to perform urodynamics before mid-urethral sling surgery for female stress urinary incontinence?
por: Houwert, R. Marijn, et al.
Publicado: (2009)

Effects on Depression and Anxiety After Mid-Urethral Sling Surgery for Female Stress Urinary Incontinence
por: Kinjo, Manami, et al.
Publicado: (2020)

The Current Role of the Artificial Urinary Sphincter in Male and Female Urinary Incontinence
por: Islah, MAR, et al.
Publicado: (2013)

Risk factors for persistent stress urinary incontinence after mid-urethral procedures
por: Chawla, Arun, et al.
Publicado: (2008)

Repeat mid-urethral sling in management of recurrent or persistent stress urinary incontinence
por: Liu, Xian-Hui, et al.
Publicado: (2020)

Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction
por: Lee, Cheng-Ling, et al.
Publicado: (2022)

Recent research on the role of urodynamic study in the diagnosis and treatment of male lower urinary tract symptoms and urinary incontinence
por: Jiang, Yuan-Hong, et al.
Publicado: (2017)

Single piece artificial urinary sphincter for secondary incontinence following successful repair of post traumatic urethral injury
por: Kandpal, D. K., et al.
Publicado: (2013)

Satisfaction with Urinary Incontinence Treatments in Patients with Chronic Spinal Cord Injury
por: Chen, Sheng-Fu, et al.
Publicado: (2022)

Predictors of Voiding Dysfunction after Mid-urethral Sling Surgery for Stress Urinary Incontinence
por: Kim, Jin Wook, et al.
Publicado: (2012)

Present value of the Urethral mobility test as a tool to assess Stress urinary incontinence due to Intrinsic sphincteric deficiency
por: Robledo, Daniela, et al.
Publicado: (2020)

A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients
por: Chang, Yi-Huei, et al.
Publicado: (2020)

Clinical Outcomes of Mid-Urethral Sling (MUS) Procedures for the Treatment of Female Urinary Incontinence: A Multicenter Study
por: Chmaj-Wierzchowska, Karolina, et al.
Publicado: (2022)

The impact of incontinence etiology on artificial urinary sphincter outcomes
por: Miller, Adam R., et al.
Publicado: (2017)

Long-term re-procedure rate after mid-urethral slings for stress urinary incontinence
por: Tulokas, Sari, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_24qncmfgad7q4400aii5dbs2fi